AUA: Upper Tract Urothelial Carcinoma (2023): Difference between revisions

Line 89: Line 89:


==== Other ====
==== Other ====
*'''Cystoscopy to assess lower urinary tract'''
*'''<span style="color:#ff0000">Cystoscopy to assess lower urinary tract</span>'''
** Essential component of the evaluation for patients with suspected UTUC due to the risk of concurrent lower tract urothelial cancer in this population
** Essential component of the evaluation for patients with suspected UTUC due to the risk of concurrent lower tract urothelial cancer in this population


* '''Upper tract endoscopy +/- biopsy of any identified lesion'''  
* '''<span style="color:#ff0000">Upper tract endoscopy +/- biopsy of any identified lesion</span>'''  
**'''Diagnostic ureteroscopy'''
**'''<span style="color:#ff0000">Diagnostic ureteroscopy</span>'''
***'''Indications for ureteroscopy or percutaneous endoscopy of the upper urinary tract (and when diagnostic and prognostic details are needed)'''
***'''Indications for ureteroscopy or percutaneous endoscopy of the upper urinary tract (and when diagnostic and prognostic details are needed)'''
***#'''Lateralizing hematuria'''
***#'''Lateralizing hematuria'''
***#'''Suspicious selective cytology'''
***#'''Suspicious selective cytology'''
***#'''Radiographic presence of a mass or urothelial thickening'''
***#'''Radiographic presence of a mass or urothelial thickening'''
***'''Document key descriptive features of UTUC including:'''
***'''<span style="color:#ff0000">Document key descriptive features of UTUC including:'''
***# '''Location (ureteral segment, renal pelvis, calyceal sites and lower tract)'''
***# '''<span style="color:#ff0000">Location (ureteral segment, renal pelvis, calyceal sites and lower tract)'''
***#'''Size'''
***#'''<span style="color:#ff0000">Size'''
***# '''Number'''
***# '''<span style="color:#ff0000">Number'''
***# '''Focality'''
***# '''<span style="color:#ff0000">Focality'''
***# '''Appearance (sessile, papillary, flat/villous)'''
***# '''<span style="color:#ff0000">Appearance (sessile, papillary, flat/villous)'''
***#Quality of visualization  
***# '''<span style="color:#ff0000">Quality of visualization </span'''
***##Can impact the accuracy of endoscopic inspection (e.g., bleeding, difficulty in access, tumor location, artifacts from instrumentation) and should be documented in endoscopic reports.
***##Can impact the accuracy of endoscopic inspection (e.g., bleeding, difficulty in access, tumor location, artifacts from instrumentation) and should be documented in endoscopic reports.
***## These factors may guide further diagnostic testing and inform therapeutic interventions as well as provide points of comparison for subsequent ureteroscopic surveillance.
***## These factors may guide further diagnostic testing and inform therapeutic interventions as well as provide points of comparison for subsequent ureteroscopic surveillance.